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Background: Plasminogen activator inhibitor 2 (PAI-2) is a member of the
serpin family of protease inhibitors that function via a dramatic structural change
from a native, stressed state to a relaxed form. This transition is mediated by a
segment of the serpin termed the reactive centre loop (RCL); the RCL is
cleaved on interaction with the protease and becomes inserted into β sheet A
of the serpin. Major questions remain as to what factors facilitate this transition
and how they relate to protease inhibition. 
Results: The crystal structure of a mutant form of human PAI-2 in the stressed
state has been determined at 2.0 Å resolution. The RCL is completely disordered
in the structure. An examination of polar residues that are highly conserved across
all serpins identifies functionally important regions. A buried polar cluster beneath
β sheet A (the so-called ‘shutter’ region) is found to stabilise both the stressed
and relaxed forms via a rearrangement of hydrogen bonds.
Conclusions: A statistical analysis of interstrand interactions indicated that the
shutter region can be used to discriminate between inhibitory and non-inhibitory
serpins. This analysis implied that insertion of the RCL into β sheet A up to
residue P8 is important for protease inhibition and hence the structure of the
complex formed between the serpin and the target protease.
Introduction
The activation of plasminogen is intrinsic to a variety of bio-
logical and pathological processes, including intravascular
fibrinolysis, tissue remodelling, cell growth and migration,
ovulation and tumour metastasis. Plasminogen activator
inhibitor 2 (PAI-2) is a potent inhibitor of urinary plasmino-
gen activator (urokinase) and to a lesser extent inhibits
tissue plasminogen activator. PAI-2 is a member of the
serpin protein superfamily and has been found in mono-
cytes, plasma, gingival crevicular fluid, various fibroblasts
and placenta [1].
Serpins are an unusual family of serine protease inhibitors.
As part of their mode of action, they undergo one of the
most radical structural rearrangements yet characterised for
a protein [2]. The intact, native protein is in a metastable
conformation known as the stressed state. On interacting
with a target protease, the serpin undergoes a transition to a
more stable, cleaved state. This interaction is mediated by a
segment of the serpin known as the reactive centre loop
(RCL). Cleavage of this loop by other non-target proteases
also induces the conversion of the serpin from the stressed
to a cleaved, relaxed state.
The nature of the stressed-to-relaxed transition became
apparent when the first serpin crystal structure, the relaxed
(cleaved) form of human α1-proteinase inhibitor (also
known as α1-antitrypsin), was solved [3]. The most promi-
nent structural feature of a serpin is the large flat β sheet A
(Figure 1; serpin secondary structure elements are labelled
as per Loebermann et al. [3]). In the relaxed form this
β sheet consists of six antiparallel β strands; the break in
the polypeptide chain due to the relaxing proteolytic cleav-
age is situated at the C-terminal end of β strand s4A. In
the stressed form, β strand s4A is not part of β sheet A ren-
dering it a mixed five-stranded β sheet [4,5]. In the stressed
state of PAI-2, the residues that would form β strand s4A
are in a disordered state on top of the protein (Figure 1).
These residues constitute the RCL which is the recogni-
tion sequence for the target protease.
The metastability of the native, stressed serpin confor-
mation has led to the evolution of a range of structural
behaviour within the serpin family. A significant number
of serpin family members are not protease inhibitors; in
most of these, the RCL of the protein does not insert into
β sheet A following proteolysis under normal conditions.
Ovalbumin is the paradigm example of a non-inserting
serpin. Of the inhibitory serpins, some are activated by
heparin and other glycosaminoglycans (e.g. antithrombin
III, heparin cofactor II and PAI-1) while others are not
(e.g. α1-proteinase inhibitor, C1 inhibitor and PAI-2). Some
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serpins (e.g. PAI-1 and antithrombin) can adopt an inac-
tive latent form where the RCL is inserted into its own
β sheet A without proteolysis. In addition, some serpins
can insert their RCLs intermolecularly, resulting in the
formation of inactive serpin polymers.
The extreme structural plasticity shown by members of
the serpin family raises many questions fundamental to
our understanding of protein structure. What prevents the
RCL from premature insertion into β sheet A in the
majority of serpins? How do the central strands of β sheet
A (s3A and s5A) accommodate their two alternative strand
partners (each other in the parallel, stressed form, and
inserted strand s4A in the antiparallel relaxed form)? How
does the core region underlying β sheet A accommodate
both the stressed and relaxed structures? By what mecha-
nism are the central strands separated during the stressed
to relaxed transition? And what determines whether a
serpin is of the inserting, inhibitory type? The aim of our
structural studies on PAI-2 is to address these issues con-
cerning the mechanism of serpin action.
We have determined the crystal structure of a mutant
form of PAI-2 in the stressed state at 2.0 Å resolution.
The RCL is disordered in our structure as there are no
fortuitous crystal contacts to stabilise it. We have exam-
ined the locations of some polar residues that are highly
conserved across all serpins. In particular, a polar cluster
beneath β sheet A appears to be crucial for the transition
between the stressed and relaxed forms. This so-called
‘shutter’ region is the site at which residue P8 of the
RCL inserts into β sheet A (where the P numbers for
protease target sequences refer to the scheme of Schechter
and Berger [6]). Using statistical parameters for residue
pairing across antiparallel β sheets, we find that there is a
correlation between the identity of the residue at posi-
tion P8 in the RCL and the inhibitory properties of the
serpin. Thus, we propose a model in which the RCL must
insert up to residue P8 in order for a serpin to act as a
protease inhibitor.
Results and discussion
Structure determination
We have determined the crystal structure of a mutant
form of recombinant human PAI-2 (Table 1). This
mutant protein was constructed by deleting the long loop
between the C and D helices, which is unique to PAI-2
[7]. The protein is fully functional as an inhibitor of
urokinase [7], but is no longer a substrate for transgluta-
minase due to the loss of the three target glutamine
residues in the C–D loop [7]. The crystals of this protein
diffract beyond 2.0 Å resolution. Initial phases were
obtained using molecular replacement methods and the
structure has been refined to an R factor of 0.20 with an
R free of 0.26. 
Description of the structure
The X-ray structure of the stressed form of PAI-2 is shown
in Figure 1. The secondary structure of the protein is
mapped onto the amino acid sequence in Figure 2.
Throughout this paper, canonical serpin numbering based
on the sequence of the α1-proteinase inhibitor will be
used in order to facilitate discussion of serpin mechanism.
Where specific features of PAI-2 are discussed, PAI-2
gene sequence numbers will be used — these can be dis-
tinguished as they will be followed by ‘(P)’. Figure 2
includes a structure-based sequence alignment of PAI-2
with α1-proteinase inhibitor in order to facilitate intercon-
version of the sequence numbering.
As seen in Figure 1, PAI-2 shows the expected stressed
serpin fold. There are several disordered regions of the
model that are localised around the top of the molecule
(Figure 1). These include the RCL (residues 368(P)–
384(P)), the loop connecting β strand s2A to the D helix
(residues 116(P)–121(P)) and several smaller regions. We
have modelled 197 ordered water molecules into the
structure. Of these, only one is totally buried and lies in
the conserved buried polar cluster beneath β sheet A, as
discussed below.
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Figure 1
Ribbon representation of the PAI-2 loop-deletion mutant in the active,
stressed state. Secondary structure elements discussed in the text are
labelled using the terminology of Loebermann et al. [3]. The structural
elements are colour coded: α helices are in purple, β sheet A is in
green, β sheet B in red and β sheet C in cyan. Sections of the
polypeptide chain with no clear electron density are indicated by
breaks in the ribbon. (The figure was produced using the program
MOLSCRIPT [53].)
Comparison with other serpins
We have compared the structure of PAI-2 with those
of ovalbumin [8] and horse leucocyte elastase inhibitor
(HLEI) [9], as the coordinates of these structures are the
only ones available for serpins determined at 2.0 Å reso-
lution or better. These three serpins are all members of
the ov-serpin family, with ovalbumin and HLEI showing
39% and 50% sequence identity, respectively, to PAI-2
[10]. The ovalbumin structure is of the stressed form
though it is non-inhibitory. In contrast, the HLEI struc-
ture is in the inserted, relaxed form. Using the backbone
atoms from β strands s5A, s6A, s3B, s4B, s5B and s6B, a
least-squares superposition of PAI-2 onto ovalbumin and
HLEI resulted in root mean square (rms) deviations of
0.34 and 0.51 Å, respectively.
There is one region in which PAI-2 is significantly dif-
ferent from all other available serpin structures. In other
serpins, there is a short helical turn between residues 198
and 203, just preceding β strand s4C. This lies just above
the conserved residue Glu342, which is at the C termi-
nus of β strand s5A (Figure 1). In other serpins, Glu342
forms a hydrogen bond with the conserved residue Thr203
and a salt bridge to Arg290 (lysine in the α1-proteinase
inhibitor) on β strand s6A. In PAI-2, Thr203 is replaced by
an asparagine residue and the helical turn between residues
198 and 203 is replaced by an extended chain. Glu342
interacts with Lys200 and Gln290 in PAI-2 (Lys214(P) and
Gln311(P), respectively), replacing the normally conserved
threonine and arginine/lysine. The altered region in
PAI-2, from Glu213(P) to Tyr220(P), is more flexible
than the body of the protein, as evidenced by higher
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Table 1
Data collection and refinement statistics.
Number of crystals 1
Number of measured reflections 176,011
Number of unique reflections 27,274
Maximum resolution (Å) 2.0
Completeness of data (%) 99 (90.5)
Rmerge* (%) 0.055 (0.35)
Number of protein atoms 2057
Number of water molecules 197
Crystallographic R factor† 0.202
R free‡ 0.268
Rmsd bond lengths§ (Å) 0.017
Rmsd bond angles§ (°) 2.9
Mainchain torsion angles§
preferred (%) 89.4
allowed (%) 10.6
generously allowed (%) 0.0
Statistics for the highest resolution shell (2.1–2.0 Å) are shown in
brackets. *Rmerge = ∑∑i[I(h)–I(h)i] / ∑∑i[I(h)i], where I(h) is the
measured mean intensity after rejections. †Crystallographic
R factor = ∑[|Fo|–|Fc|] / ∑|Fo|, where Fo and Fc are the observed and
calculated structure factors, respectively, and the summations are over
all unique reflections. ‡The free R factor [47] is calculated as for the
crystallographic R factor except that the summation is over a test set of
8% of unique reflections that were omitted from the refinement.
§From PROCHECK [52]; values are the root mean square deviations
(rmsds) from ideal values.
Figure 2
Structure-based sequence alignment of PAI-2 and α1-antiproteinase
(α1-AP). The upper numbering scheme is for the PAI-2 gene
sequence; the lower numbers are derived from α1-antiproteinase. By
convention, the α1-antiproteinase sequence numbers are used to
discuss the properties of PAI-2 in the text. Secondary (2°) structure
elements are indicated by bars above the sequence that are coloured
as in Figure 1. Residues that are more than 90% conserved in serpins
are highlighted in yellow. The residues in PAI-2 that are highlighted in
dark blue (the C–D loop) have been deleted from our construct.
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B factors and a break in the electron density between
residues Leu215(P) and Leu219(P).
Disorder and mobility of the RCL
The PAI-2 crystals appear to be unique amongst those
reported for stressed serpins in that the RCL region borders
a large solvent channel. Thus, the conformation of the RCL
cannot be stabilised by any neighbouring PAI-2 molecules.
The result is that the RCL is highly disordered showing
no clear electron density between Thr367(P) (nested in
the loop at the C terminus of β strand s3A; Figure 3) and
Pro386(P) at the N terminus of β strand s1C. The electron
density ends abruptly at the N-terminal end of the RCL,
although there is weak density for the backbone of approxi-
mately three residues preceding Pro386(P).
We confirmed that the RCL was intact in our crystals by
dissolving them in both reducing and non-reducing unfold-
ing buffers and determining the molecular weight of the
protein via electrospray mass spectrometry. We obtained a
clean spectrum from the non-reducing buffer with a mol-
ecular weight of 43,128 Da. Reduction and heating pro-
duced an additional peak at 43,046 Da. These values corre-
spond to the molecular weights of N-terminally acetylated
mutant PAI-2 with and without a single mercaptoethanol-
modified cysteine. No evidence for fragments corre-
sponding to cleavage products could be observed in the
spectra (i.e. no peaks for smaller molecular weights such as
39,000 Da, as would be expected if RCL was cleaved).
These results were confirmed by sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS–PAGE) of dis-
solved crystals under reducing conditions.
In previously reported structures of stressed serpins, the
RCL is seen to adopt a variety of conformations. In oval-
bumin [8] and antichymotrypsin [5], it adopts a distorted
helical conformation. In α1-antitrypsin [11], the RCL is in
an extended conformation that resembles the canonical
non-serpin protease inhibitor loop [12,13]. In all cases, the
RCL makes important interactions with other molecules
in the crystal. Where reported, the temperature factors for
the RCL indicate that this region is disordered. Combin-
ing these observations with our results for PAI-2, we con-
clude that the RCL is flexible, alternating between a
variety of conformations. The stabilisation of any particu-
lar conformation requires interaction with a neighbouring
molecule, such as the target protease itself.
Spin-echo nuclear magnetic resonance (NMR) experiments
have also been used to examine the mobility of the RCL
[14]. Hood and Gettins compared stressed and modified
α1-proteinase inhibitors and ovalbumin with plakalbumin
(i.e. ovalbumin with the region corresponding to the RCL
cleaved but not inserted). These experiments concluded
that the RCL was no more mobile than the body of the
serpin on the time scale of the spin-echo experiment.
From the above data, we argue that the natural state of the
RCL is disordered, switching between a variety of con-
formers. This flexible loop architecture is in keeping with
its functional roles: it must be readily accessible for inser-
tion into both the active site of a target protease and its
own β sheet A.
These findings are in line with results of limited proteoly-
sis experiments, which showed that peptide bonds between
residues P10 and P1′ are susceptible to proteolysis in
stressed serpins [15,16].
Conserved residues: essential interactions for serpin
function
Huber and Carrell [17] examined the role of conserved
residues in serpin function. We have extended this analy-
sis by using structure-based alignments of serpin amino
acid sequences to identify highly conserved residues.
Those residues that are conserved with greater than 90%
identity in over 200 serpin sequences are highlighted on
the sequence of PAI-2 (Figure 2). Half of these residues
are nonpolar and form parts of the protein hydrophobic
core. A quarter of the residues are prolines or glycines that
are likely to have structural and/or functional importance.
The remaining conserved residues are polar. The distribu-
tion of conserved polar residues in the serpin family is of
considerable interest as they provide clues to the mecha-
nism of loop insertion and protease inhibitory action.
In the stressed PAI-2 structure (Figures 1 and 3), β strands
s3A and s5A are prised apart at the top of β sheet A
where β strand s4A would commence insertion. Working
from the C termini of β strands s3A and s5A, interstrand
hydrogen bonding does not commence until residues 338
(Val360(P)) and 190 (Phe204(P)) on β strands s3A and s5A,
respectively. Underlying the fork between β strands s3A
and s5A are the conserved aromatic residues Trp194 and
Tyr/Phe244. These large aromatic residues cause the sep-
aration between the two β strands in preparation for inser-
tion. In the structure of PAI-2, the gap between the
C-terminal four residues of strand s5A and the correspond-
ing residues of strand s3A is bridged by a cluster of bound
water molecules (Figure 3).
The conserved Glu342 is at the top of β strand s5A
(Figure 3) forming its terminating point. This residue acts
as a hinge for the RCL, which either leaves β sheet A in
the stressed state or makes a sharp turn to insert β strand
s4A into β sheet A. To fulfil this role, the sidechain of
Glu342 is normally held in position by hydrogen bonds to
the conserved residues Thr203 and Arg290. As described
above, this site is altered in PAI-2 with residues Lys200
and Gln290 anchoring Glu342. The importance of the
anchoring of this glutamate sidechain is evidenced by the
aberrant properties of the Z variant of human α1-anti-
trypsin in which Glu342 is mutated to lysine [18].
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Figure 3
Stereoviews of the top end of β sheet A in the
active, stressed state structure of PAI-2.
(a) Shown are the sidechains of Trp194
(208(P)) and Tyr244 (258(P)), which prise
apart β strands s3A and s5A in preparation
for the insertion of the RCL to form β strand
s4A. The three lower green spheres represent
the ordered water molecules that fill the gap
between β strands s3A and s5A, maintaining
the hydrogen bonding between them. Also
shown is the sidechain of Glu342 (364(P)).
This residue anchors the end of β strand s5A
and acts as a hinge point for the formation
and insertion of β strand s4A. Note that
canonical sequence numbering has been
used to simplify discussion. (b) A stick model
showing the same region of PAI-2 as in (a).
The hydrogen bonds (pale blue dotted lines)
that stabilise the backbone of the N-terminal
region of the RCL are shown at the top of the
figure along with the last three backbone
hydrogen bonds linking β strands s3A and
s5A (lower portion of the figure). Water
molecules are represented as green crosses.
(c) A representative portion of the electron
density (2Fo–Fc map contoured at 1σ). This
region corresponds to the lower portion of
Figure 3b. (The figure was created using the
program SETOR [54].)
  190  190
Structure
(c)
(b)
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The most striking cluster of conserved polar residues is
formed by His334, Asn186 and Ser53 together with the
adjacent Ser56 residue, which is conserved to a lesser
extent (80%). These residues are buried within the protein
core (Figure 4) and are central to the shutter region
described by Stein and Carrell [19]. They lie at the point
where the edge of β sheet B contacts the underside of
β sheet A. The fact that the edge of β sheet B is buried
necessitates the burial of polar residues in order to prevent
the energetically unfavourable burial of unfulfilled back-
bone NH and C = O groups on its edge β strand. Ser53 is
on β strand s5B of β sheet B while His334 and Asn186 are
on β sheet A. In particular, Asn186 and His334 are on
β strands s3A and s5A, respectively, thus, they straddle
the site of the serpin β strand insertion. It is likely that
this conserved buried polar cluster is important for the
mechanism of β-sheet opening and the concomitant
strand insertion.
An examination of the structure of this cluster in stressed
PAI-2 shows a network of hydrogen bonds (Figure 4a).
The HNε of His334 is hydrogen bonded to the backbone
NH of Ser53. The sidechain OH of Ser53 is linked to the
backbone NH of buried Ser56 and to the sidechain OH of
Ser56. The HNδ of Asn186 completes the circle of hydro-
gen bonds by linking to the sidechain OH of Ser56 and
the HNδ of His334. Clearly, this network must be dis-
rupted by the insertion of the RCL to form β strand s4A.
To compare this with the relaxed state, we used the high-
resolution coordinates of HLEI (Figure 4b). Many of the
hydrogen bonds seen in stressed PAI-2 are present in
relaxed HLEI. HNε of His334 is still hydrogen bonded to
the backbone NH of Ser53. Likewise the sidechain OH of
Ser53 forms a hydrogen bond to the backbone NH of
Ser56 and the sidechain OH of Ser56 still interacts with
the HNδ of Asn186. 
The major difference in this region appears to be a ‘swing-
ing’ of the sidechain of Ser56, which allows it to follow
Asn186 as it moves to allow the introduction of the new
β strand s4A. The hydrogen bond between the sidechain
OH groups of Ser56 and Ser53 is broken. Similarly, the
hydrogen bond between the HNδ of Asn186 and HNδ of
His334 is broken.
The link between His334 and Asn186 is not completely
lost in the relaxed structure of HLEI, although the inser-
tion of β strand s4A introduces Thr351 between these
residues. There is a hydrogen bond from HNδ of His334
to the sidechain OH of Thr351 and a hydrogen bond from
the OH group of Thr351 to the HNδ of Asn186. The HNδ
of His334 also forms a hydrogen bond to the backbone
C = O of Ala350. This link between His334 and Asn186 in
the relaxed form is not present in all serpins as it depends
on the nature of residue 351 (discussed below). 
We have also examined this region in the partially inserted
form of intact antithrombin [20]. The buried polar cluster
appears to be intact, although a detailed examination is
not warranted due to the limited resolution of the struc-
ture. The partial insertion of β strand s4A in this structure
has ruptured many hydrogen bonds between β strands s3A
and s5A. It may be significant that regular interstrand
hydrogen bonding is restored at residues His334 and
Asn186 in this partially inserted state.
Most serpins with deviations from the conserved residues in
the buried polar cluster are inactive as protease inhibitors.
There are, however, several important exceptions: PAI-1
and nexin with His334→Gln and Ser56→Gly; and heparin
cofactor II with Ser53→Ala and Ser56→Gly. We note that
these particular serpins are all activated by glycosamino-
glycans. The alterations in the buried polar cluster may
have a role in activation of these inhibitory serpins.
Determinants of loop insertion
The insertion of an extra β strand into a β sheet poses
some interesting design problems for serpin evolution. In
a normal β sheet, cross-strand residue pair interactions are
optimised by selecting the appropriate β-strand sequences
so that optimal interstrand sidechain interactions occur
[21]. These interstrand sidechain interactions are impor-
tant for β sheet, and hence protein, stability [22]. The
probability that a particular pair of amino acids are inter-
strand neighbours is dependent on whether the β strands
are parallel or antiparallel and on their backbone hydro-
gen-bonding state [21,23].
In inhibitory serpins, the sequences of β strands s3A and
s5A must be selected to optimise sidechain interactions
with each other in a parallel orientation and antiparallel
sidechain interactions with the inserted β strand s4A. Any
mutations that favour only one of these situations will alter
serpin function. Thus, the residues in β strands s3A and
s5A have unusual requirements.
Residue pair correlations have been determined for both
antiparallel and parallel β sheets [21,23]. Using this statis-
tical data, it should be possible to determine which inser-
tion sites for β strand s4A are critical. Once these sites are
determined, it should then be possible to partition related
serpins into inserting and non-inserting classes.
Figure 5 shows the comparison of the pair correlation para-
meters for PAI-2 in the inserted (relaxed) and non-inserted
(stressed) forms. The sites have been labelled S14, S13 etc,
which corresponds to the labelling of the RCL residues that
either will be or have been inserted into β sheet A (after the
scheme of Schechter and Berger [6]). The figure shows that
the pattern of residue correlation parameters are similar for
both the stressed and the relaxed forms of PAI-2. For most
sites, the residue pair parameters are nondiscriminating
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(i.e. close to 1.0). There are two sites with high correlations:
S13 and S8. These high correlations are present for both the
stressed and relaxed forms. 
The S13 site is on the solvent-exposed surface of β sheet
A. Upon insertion, residue P13 is flanked by residues 191
and 339 on β strands s3A and s5A, respectively. Residue
191 is moderately conserved (80% identity) with lysine as
the most common amino acid; residue 339 is normally
polar (glutamate 33%, threonine 25% and aspartate 20%).
Thus, this site would favour a polar residue at position P13
(residue 346). The most common residue at P13 is glu-
tamic acid (73%). This is true for both inserting and non-
inserting serpins. Most mutations at this site are to other
polar residues. PAI-1 is unusual in having valine at this
site. The high correlations at the S13 site suggest the impor-
tance of electrostatic interactions in both the stressed and
relaxed forms. This site is not a good discriminator between
inserting and non-inserting serpins.
The S8 site is under β sheet A (i.e. in the protein core): it
is the buried polar cluster of conserved residues (His334
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Figure 4
Stereoviews of the buried polar cluster in the
shutter region beneath β sheet A. The shutter
region as seen in (a) the structure of stressed,
active PAI-2, and (b) in the relaxed, inserted
form of HLEI. Atoms are shown in standard
colours. Hydrogen bonds are represented as
dotted yellow lines. In the active PAI-2
structure, a ring of hydrogen bonds link
His334 (356(P)), Ser53 (31(P)), Ser56
(34(P)) and Asn186 (200(P)). In the inserted
form, the hydrogen bond between the serines
is broken, allowing Ser56 to swing while
remaining hydrogen bonded to Asn186, thus
facilitating the separation of β strands s3A
and s5A. The insertion of β strand s4A re-
establishes the ring of hydrogen bonds by
coupling His334 with Asn186 via backbone
and sidechain hydrogen bonds mediated by
Thr351. Also seen in the PAI-2 structure is
the buried ordered water molecule (red
sphere, lower left) which fills a hole beneath
the shutter region. Note that canonical
sequence numbering has been used in this
figure to simplify comparison. (The figures
were made with the program SETOR [54].)
and Asn186) that has been discussed above. The observed
high correlations between adjacent residues are again due
to electrostatics. Residue 351 that occupies position P8 is
not as strongly conserved as residue P13. 
To examine whether the S8 site can discriminate between
inserting and non-inserting serpins, the residue correlation
parameters were calculated for all P8 residues observed in
serpins with histidine at position 334 and asparagine at
186. Figure 6 shows a bar graph of the results of these cal-
culations. One observes that all residues with a correlation
parameter above 1.5 are found in inhibitory serpins. Like-
wise, all residues with a correlation parameter below 0.75
are non-inhibitory. The only intermediate value is for
methionine, which is found in the inhibitory serpin α1-
antiproteinase (correlation parameter 0.86). Thus, it
appears that the S8 site is not only crucial for the separation
of β strands s3A and s5A but can also discriminate
between inhibitory and non-inhibitory serpins.
We note that PAI-1 differs from most serpins in the
shutter region by having a glutamine at position 334
instead of a histidine residue. This substitution does not
affect the polar character of the site nor does it alter the
statistical correlation at P8. The correlation parameter for
the inserted form of PAI-1 is 2.9, which compares well
with other inhibitory serpins (Figure 6).
Release mechanism
Given the favourable electrostatic interactions in the inserted
form, an important question still remains: What prevents
premature insertion and the formation of the latent form in
the majority of serpins? Given the disorder in the PAI-2
RCL, insight into the stabilising mechanism can be gained
by examining the factors that maintain the order of the two
crystallographically observed ends of the loop.
An examination of the proximal hinge region of the RCL
shows that residues 365(P)–367(P) (P16–P14) are stabilised
by a series of backbone hydrogen bonds (Figure 3b) to
the loop formed by the C-terminal end of β strand s3A
and the ensuing residues (Lys207(P)–Phe210(P); Figure 1).
Thr367(P) is the last ordered residue visible in the RCL in
our structure. An examination of other stressed serpins
shows that this network of hydrogen bonds is conserved in
ovalbumin [8] and α1-antitrypsin [11]. Ovalbumin is further
stabilised by hydrogen bonds from residues 195 and 197 to
residue P13. These additional interactions are not present
in PAI-2 nor α1-antitrypsin because residue 197 is a proline.
The integrity of this network of hydrogen bonds in the
native, stressed serpin is supported by the results of limited
proteolysis studies [15,16], which show that peptide bonds
between residues P15 to P10 are not susceptible to cleavage
via a battery of proteases. From our structure, residues P16
to P15 are attached to the body of PAI-2 via hydrogen
bonds. A protease attacking the RCL is thus unlikely to cut
it prior to residue P10 if it requires three residues to bind to
its active site on the C-terminal side of the scissile bond.
The stability of this hydrogen-bond network is further
enhanced by the balance of oppositely charged residues on
the RCL proximal hinge (P15–P12) and the loop between
the top of β strand s3A and the ensuing residues (195–197).
The former usually has a net charge of –1, while the latter is
either neutral or +1. PAI-3 is unusual as the hinge segment
has a charge of +1 and the loop a charge of –1.
In the crystal structures of antithrombin III with partially
inserted RCLs, this network of hydrogen bonds is broken
[20,24]. In these structures, the RCL is induced to adopt
an extended conformation by displacing β strand s1C in
β sheet C of a partner serpin that is in a latent form. The
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Figure 5
A comparison of the residue pair correlations calculated for the
centre of β sheet A in the stressed and relaxed forms of PAI-2. Sites
along the β sheet are labelled ‘S16, S15’ etc as with serine protease
numbering [6]. For the stressed, non-inserted state (filled bars), the
residue correlations are based on pairwise, parallel cross-strand
correlations for the bridging neighbours occurring on β strands s3A
and s5A. For the relaxed, inserted form (open bars), the correlation at
a particular site is the product of the antiparallel cross-strand pair
correlations for the neighbouring residues on β strands s3A and s4A
and the correlation for the neighbouring residues on β strands s4A
and s5A at the same site. Statistical data were obtained from Cootes
et al. [23].
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authors propose that the interaction of the RCL with the
second serpin mimics the initial Michaelis complex of a
serpin with a target protease. Our view is that this initial
complex stretches the RCL sufficiently to disrupt the
hydrogen-bond network that otherwise prevents premature
insertion. We note that the partial insertion of the RCL has
increased the number of hydrogen bonds made by the RCL
to the serpin body. This is almost exactly offset by the
number of hydrogen bonds ruptured between β strands s3A
and s5A to accommodate the partial insertion.
Latency
The regions that we propose stabilise the RCL against pre-
mature insertion are also present in PAI-1, which readily
undergoes a transition to an inserted latent form. Thus,
there must be some other region of the protein that discrim-
inates between latency-prone serpins and stressed serpins. 
A common element in the observed structures of latent
PAI-1 and latent antithrombin is the removal of β strand
s1C from the edge of β sheet C. It was once thought that
removal of β strand s1C was necessary for serpin inhibitory
activity, but Hopkins et al. [25] have shown that α1-anti-
trypsin is fully active when β strand s1C is covalently
bound to β sheet C. Thus, lability of β strand s1C is likely
to be a characteristic of latency-prone serpins.
We examined the interactions between the parallel
β strands s1C and s2C for all the available serpin structures
(i.e. HLEI, ovalbumin, PAI-2, α1-antiproteinase, antichy-
motrypsin and antithrombin) plus PAI-1 via homology mod-
elling. We compared statistical pair correlation values for
residues 362–366 on β strand s1C interacting with residues
284–288 on β strand s2C. On the basis of these statistical
scores, we could not distinguish latency-prone serpins. 
However, PAI-1 does appear to have a destabilising site in
β sheet C. Residue 284 is an arginine which although
favourably partnered with Glu362 appears to be buried
beneath β sheet C (Glu362 is on the edge strand of the
β sheet). The next residue, Leu285, is exposed on the
surface in a position occupied by a polar amino acid in all
cases except antithrombin, which has a valine at this posi-
tion. It is possible that Arg284 and Leu285 severely desta-
bilise β sheet C in PAI-1 inducing latency in PAI-1, while
Val285 mildly destabilises β sheet C in antithrombin. We
note that the statistical parameters calculated for the inter-
molecular β sheet formed in the antithrombin dimer
crystal structure [20] have similar cross-strand residue pair
correlation values as the native pair of β strands. 
Model for serpin stressed-to-relaxed state transition:
implications for protease inhibition
By combining the available structural and sequence data
with the results of the present study, a model for the mech-
anism of serine protease inhibition by serpins is presented.
In the stressed state, the RCL is held in position at the top
of the serpin via a network of hydrogen bonds in the prox-
imal hinge region assisted by sidechain electrostatic inter-
actions. The parallel strands in the centre of β sheet A
(s3A and s5A) are held ‘prised apart’ at their C termini by
the steric effects of Trp194 and Tyr/Phe244 below, and
the electrostatic interactions pinning the sidechain of Glu342
at the very C terminus of strand s5A. Thus, the serpin is
poised ready to insert the RCL into β sheet A.
On interacting with the protease, the hydrogen bonds
holding the proximal hinge region (residues P13–P16) are
broken. The structure now resembles that of stressed anti-
trypsin where the RCL is in an extended conformation
[11]. Shortly thereafter, the protease forms the covalent
acyl intermediate and releases the newly formed N termi-
nus at residue P1′ [26,27]. This allows the partial insertion
of β strand s4A into β sheet A up to about P14–P10 with
the structure resembling the partially inserted form of
antithrombin [20,24]. 
At the S8 site, the buried polar residues rearrange their
hydrogen-bonding pattern in a way that allows the strands
to separate in the middle portion of β sheet A. The inser-
tion of the RCL will only continue to the S8 site if the
correct residue is present at P8. Failure to insert at S8 is
likely to result in the serpin acting as a substrate instead of
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Figure 6
The calculated residue correlation for the (putative) inserted form of
serpin at site S8 for all observed P8 amino acids that occur in serpins
with histidine at residue 334 and asparagine at 186. The solid bars
represent inhibitory serpins and the open bars represent non-inhibitors.
The correlations have been calculated as the product of the two
antiparallel bridging pair correlations at site S8 (i.e. the pair of residues
on β strands s3A and s4A and the pair on β strands s4A and s5A).
Examples of serpins containing a particular amino acid at residue 351
are listed next to the corresponding bar on the graph. Statistical data
were obtained from Cootes et al. [23].
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an inhibitor. However, α1-antiproteinase is a possible
exception with methionine at this position. Thus, there
may be alternative modes of action.
Our model suggests that for a serpin to be inhibitory, the
RCL needs to insert to about P8. This is supported by
fluorescence measurements, which show that P9 interacts
with β sheet A in PAI-1 [28]. This differs from currently
proposed models that only insert to about P12–P10 [29,30].
The argument for insertion only to P10 relies on mutage-
nesis data involving the mutation of P even numbered
residues to glutamate [31]. These studies showed that a
mutant of α1-antitrypsin, in which P8 was converted to glu-
tamate (P8→Glu), was fully active as an inhibitor of elas-
tase. However, our statistical data indicates that this mutant
is likely to be an inhibitor. The glutamic acid residue at P8
will be accommodated under β sheet A by favourable inter-
actions with His334 and Asn186. This offers an alternative
explanation for the activity of P8→Glu, as opposed to the
conclusion of Hopkins and Stone [31] that the mutant was
active because insertion of P8 is unnecessary.
To test the importance of P8 insertion, we have searched
the literature for all residue substitutions at P8, either nat-
urally occurring or resulting from mutagenesis experiments.
We have only found two examples: a methionine to gluta-
mate substitution at P8 in α1-antiproteinase [31–33] and a
threonine to proline substitution in PAI-1 [34]. As dis-
cussed above, the glutamate mutant is fully active, which
is consistent with the statistical and structural analysis.
The proline-substituted PAI-1 acts as a substrate instead
of an inhibitor of tissue-type plasminogen activator. Thus,
although the interaction of this mutant protein with the
target enzyme is unaffected, its inhibitory action is
blocked. This is consistent with our model.
Peptides have also been used to probe the determinants of
RCL insertion and the inhibitory mechanism [35–37]. Incu-
bation of a native serpin with a peptide whose sequence
matches a portion of the RCL often results in the forma-
tion of a serpin–peptide complex with altered properties.
Detailed studies by Schulze and colleagues have shown
the importance of the P14 site for serpin function [35,36].
The 14-mer peptide P14–P1 converts α1-antiproteinase
into a stable substrate, whereas shorter N-terminally trun-
cated peptides (P12–P1 through to P8–P1) show a range of
behaviour — from substrate to inhibitor [36]. The simplest
interpretation is that insertion of residues P12–P1 is not
essential for inhibitory behaviour, however, the detailed
experimental characterisation of these complexes shows
that the interaction of these shorter peptides with the
serpin is quite complicated [36]. The first crystal structure
of a serpin–peptide complex shows that peptides can bind
in unexpected ways [38]. More structures of serpin–peptide
complexes are needed for a complete understanding of the
properties of these complexes.
Early models of the inhibitory complex of a serine protease
and a serpin positioned the protease on top of the serpin,
that is, where the intact RCL is located in the active form
[20,29]. The culmination of recent biochemical [26,27] and
structural data [39,40] has resulted in models where the pro-
tease is positioned in an equatorial region [30,39,40] or at the
base of the serpin [41,42]. Our results do not distinguish
between the equatorial models and the fully inserted model.
However, we propose that the RCL is inserted into β sheet
A beyond P8, in contrast to current equatorial models. 
We have examined the possibility of constructing such an
equatorial model by visually docking the structure of a
complex formed between trypsin and the amyloid protease
inhibitor to the relaxed form of HLEI [9] (PDB accession
codes 1TAW and 1HLE, respectively). Superposition of
the P7 residue of the non-serpin protease inhibitor loop
onto the inserted serpin P7 residue in HLEI resulted in a
viable model. Residues in the serpin shutter loop (that links
the F helix to β strand s5A) had to move in order to con-
struct the complex. The docking results in a very close fit of
the protease to the serpin. This contrasts with models in
which fewer residues of the RCL are inserted into β sheet
A [30]. In these models, the protease and the body of the
serpin do not appear to come into intimate contact.
The intimate contact between the serpin and the target
protease may be important for inhibition. One model for
the inhibition is that the strain introduced into the protease
by the serine-linked RCL distorts the catalytic triad so that
the protease cannot release the acyl intermediate [43]. In
order to generate strain, it is not enough for the RCL to pull
at the serine residue of the protease — it must also push
away the body of the protease. Thus, this model favours
serpin–protease complexes with intimate contact.
Biological implications
Serpins are a biologically important class of serine pro-
tease inhibitor. These inhibitors operate via an unusual
mechanism. The native protein is in a stressed state,
which offers a site of attack for the target protease called
the reactive centre loop (RCL). On interaction with the
target protease, the RCL makes a gross structural tran-
sition and inserts into the centre of the large β sheet A of
the serpin. The mechanism of protease inhibition by
serpins and the structural basis of RCL insertion have
been the topics of intense study. Plasminogen activator
inhibitor 2 (PAI-2) is a member of the serpin superfam-
ily. It is of particular interest because of its role in
intravascular fibrinolysis, tissue modelling, cell growth
and migration, ovulation and tumour metastasis. 
We have determined the structure of the serpin PAI-2 in
the stressed state. This is one of the first high-resolution
structures of an inhibitory serpin in this state. The struc-
ture shows that the RCL is disordered when it is not
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tethered by protein crystal contacts (as observed in other
structures). This is in keeping with its role as a protease-
binding site that can subsequently insert into β sheet A.
By combining our structural data with the body of avail-
able data on serpins and an analysis of sidechain interac-
tions in β sheets, we have identified key residues in the
‘shutter’ region of serpins that are implicated in RCL
insertion during target protease inhibition. In particular,
the identity of residue P8 in the RCL appears to deter-
mine whether the serpin is a functional protease inhibitor
or not. This partitioning is based on the propensity of
residue P8 to interact favourably within β sheet A. The
importance of RCL residue P8 suggests that in the serpin–
target protease complex, the RCL must insert up to at
least residue P8. Hence, in the complex the protease is
likely to reside near the centre of β sheet A, with β strand
s4A partially inserted, or at the base of the serpin with
this strand fully inserted. This model for serpin function
will act as a guide to future structure/function studies.
Materials and methods
Protein expression and purification
Recombinant human PAI-2 loop-deletion mutant was cloned and
expressed in Escherichia coli and purified as described by Jensen et al.
[7] This mutant lacks the loop between α helices hC and hD (residues
66(P)–98(P), inclusive, in the PAI-2 gene sequence). 
Crystallographic structure determination
Crystals of the PAI-2 loop-deletion mutant were grown by vapour diffu-
sion and required seeding to grow crystals of adequate size. Seed crys-
tals were grown by vapour diffusion of 11 mg/ml PAI-2 against a reservoir
containing 15% polyethylene glycol (PEG) 8K, 0.12 M Mg(CH3COOH)2
and 0.1M HEPES (pH 7.5). Successive rounds of micro- and macro-
seeding into vapour diffusion trays that differed only in their lower PEG
8K concentration (10–13%) resulted in large high-quality crystals
(0.5 × 0.3 × 0.1 mm3). Crystals belong to the space group C2 with unit-
cell dimensions a = 138.8 Å, b = 41.7 Å, c = 77.4 Å, β = 114.9° and
contain one molecule per asymmetric unit. Diffraction data to 2.0 Å reso-
lution were collected at the Stanford Synchrotron Radiation Laboratory
(SSRL) beamline 7.1, with an X-ray wavelength of 1.08 Å on a MAR
online image plate detector. A single crystal of dimensions 0.4 × 0.2 ×
0.2 mm3 was washed in stabilising solution containing 25% ethylene
glycol for 1 min, held in a fibre loop and flash frozen in a stream of cold
nitrogen gas. Data were processed using the programs DENZO and
SCALEPACK [44]. 112 images with a spindle rotation of 2° yielded
176,011 integrated reflections which reduced to 27,274 independent
reflections, representing 99% (90.5% in the 2.1–2.0 Å range) of the
accessible data with an overall R merge of 0.055 (0.350 in the 2.1–2.0 Å
shell). The crystals diffract anisotropically with diffraction extending
beyond 2 Å in the favoured direction and to 2.4 Å in the weaker direction.
Molecular replacement calculations were performed with the program
X-PLOR [45]. Polyalanine search models were constructed from the
coordinates of ovalbumin (PDB accession code 1OVA) and antichy-
motrypsin (PDB code 2ACH). Rotation and translation searches showed
ovalbumin to give superior scores. The oriented ovalbumin polyalanine
model was grouped in several segments and refined as rigid bodies.
The model was compared to the calculated electron-density maps
using the program O [46]. Sidechains were mutated to the correct
amino acid, regions of the model in poor or missing density were
deleted and regions of insertions and deletions were identified.
To allow cross-validation of the model, 8% of the data were randomly
assigned to an R free set [47]. The model was progressively refined
using simulated-annealing protocols at 3000K with all data, followed by
manual inspection and rebuilding of relevant sections. Introduction of
anisotropic scaling and bulk-solvent correction improved regions of
ambiguous density. The final stages of refinement were performed with
the CCP4 suite of programs [48] and REFMAC [49]. No electron density
for residues 368(P)–385(P), which contains the RCL, was present at
any stage of the refinement. Simulated annealing omit maps at stages
throughout the model building failed to reveal any structural features
in this region of the chain. Our final model consists of residues
2(P)–115(P), 122(P)–215(P), 219(P)–367(P) and 385(P)–415(P), with
the exclusion of the engineered loop deletion between helices C and D
(residues 66(P)–98(P)). It contains 2057 protein atoms, 197 ordered
water molecules, a disulphide link between residues 5 and 405 and a
β-mercaptoethanol modified cysteine at residue 161. The refined model
has a crystallographic R factor of 0.202 with an R free of 0.268.
Figure 3c shows a representative portion of the electron density. 
Sequence alignments
The HSSP data base [50] was used to obtain alignments of serpins
against the sequences of published structures. These data sets were
used to extract sequence conservation as a function of residue. The
percentage identity was obtained directly from the HSSP files.
β-Sheet correlation parameters
Pair correlation parameters were calculated [23] using the methods
described by Wouters and Curmi [21]. The data for both parallel and
antiparallel sheets were based on the structures in the nonredundant
structure data base [51]. 
For the stressed state, the parameters presented in Figure 5 are simply
the gij values for the adjacent residues on β strands sA3 and sA5 (see
[21] for a definition of gij). For the relaxed state, the parameters in
Figures 5 and 6 are the product of two antiparallel g values. Thus, for
an inserted site, for example P13, the g value for the residue P13 and
its partner on β strand sA3 is multiplied by the g value for P13 and its
partner on β strand sA5.
Accession numbers
The coordinates of PAI-2 in the stressed state have been deposited at
the Brookhaven Protein Data Bank with accession code 1BY7.
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